Also trades as: RGEDF (OTC) · $vol 0M

$24.85

+0.00 (+0.00%)

OTC · Healthcare · Medical - Pharmaceuticals · Tech Score Neutral · Power 57 · $4.5B mcap · 183M float · 0.0002% daily turnover

Revenue

$862.6B +0.6% ▲

5Y CAGR: +8.8%

Gross Profit

$595.1B +0.7% ▲

5Y CAGR: +13.3%

Operating Income

$300.6B +15.1% ▲

5Y CAGR: +18.8%

Net Income

$215.7B -9.8% ▼

5Y CAGR: +15.6%

EPS (Diluted)

$1178.67 -9.8% ▼

5Y CAGR: +15.9%

EBITDA

$356.7B +4.1% ▲

5Y CAGR: +18.8%

View Full Income Statement

Line Item	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$630.6B	$802.8B	$805.2B	$857.5B	$862.6B
YoY Growth	+11.3%	+27.3%	+0.3%	+6.5%	+0.6%
Cost of Revenue	$281.3B	$342.3B	$283.8B	$266.8B	$267.5B
Gross Profit	$349.3B	$460.5B	$521.3B	$590.7B	$595.1B
Gross Margin	55.4%	57.4%	64.7%	68.9%	69.0%
R&D Expenses	$61.0B	$75.1B	$78.3B	$99.2B	$84.7B
SG&A Expenses	$143.3B	$182.3B	$196.6B	$221.0B	$206.9B
Operating Expenses	$213.4B	$306.9B	$332.0B	$329.6B	$294.5B
Operating Income	$135.8B	$153.6B	$189.4B	$261.2B	$300.6B
Operating Margin	21.5%	19.1%	23.5%	30.5%	34.8%
Interest Expense	$663M	$8.0B	$15.3B	$12.0B	$73.4B
Income Before Tax	$143.5B	$165.7B	$171.5B	$281.1B	$264.4B
Tax Expense	$5.4B	-$5.1B	$10.9B	$41.6B	$48.8B
Net Income	$139.6B	$169.1B	$158.8B	$239.2B	$215.7B
Net Margin	22.1%	21.1%	19.7%	27.9%	25.0%
EPS (Diluted)	$750.65	$907.39	$860.00	$1307.00	$1178.67
EBITDA	$175.6B	$233.6B	$262.6B	$342.6B	$356.7B
Shares Outstanding	186M	186M	185M	183M	183M

Line Item	FY2024 Q2	FY2024 Q3	FY2024 Q4	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1
Revenue	$216.3B	$216.7B	$221.1B	$224.0B	$241.5B	$209.8B	$245.3B	$223.9B
Cost of Revenue	$74.1B	$61.4B	$70.0B	$68.9B	$72.3B	$69.7B	$74.5B	$73.7B
Gross Profit	$142.1B	$155.3B	$151.1B	$155.2B	$169.1B	$140.1B	$170.8B	$150.3B
Gross Margin	65.7%	71.7%	68.3%	69.3%	70.0%	66.8%	69.6%	67.1%
R&D Expenses	$22.6B	$24.9B	$29.0B	$23.8B	$25.1B	$19.0B	$22.5B	$23.2B
SG&A Expenses	$55.5B	$51.2B	$62.2B	$59.2B	$59.0B	$51.1B	$51.6B	$56.3B
Operating Expenses	$79.2B	$91.6B	$80.1B	$87.4B	$96.5B	$70.1B	$75.7B	$78.0B
Operating Income	$62.9B	$63.7B	$71.0B	$67.8B	$72.6B	$70.0B	$95.1B	$72.3B
Operating Margin	29.1%	29.4%	32.1%	30.2%	30.1%	33.4%	38.8%	32.3%
Interest Expense	$16.8B	$0	$0	$41.0B	$11.3B	$12.8B	$19.3B	$15.9B
Income Before Tax	$74.4B	$45.9B	$78.6B	$82.0B	$63.1B	$50.9B	$86.4B	$80.1B
Tax Expense	$4.1B	$8.8B	$14.9B	$13.8B	$11.1B	$8.5B	$18.7B	$13.5B
Net Income	$70.0B	$37.1B	$64.0B	$68.1B	$51.8B	$42.4B	$68.1B	$66.4B
Net Margin	32.4%	17.1%	28.9%	30.4%	21.5%	20.2%	27.7%	29.6%
EPS (Diluted)	$382.92	$202.94	$348.11	$373.00	$283.75	$231.67	$373.24	$363.90
EBITDA	$75.0B	$76.4B	$61.4B	$137.0B	$43.1B	$84.9B	$111.1B	$88.6B
Shares Outstanding	183M	183M	184M	183M	183M	183M	183M	182M

GEDSF OTC